This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Susan E. Koch, MD; Toby Mathias, MD; Howard I. Maibach, MD
Department of Dermatology University of California Medical Center San Francisco, CA 94143

Arch Dermatol. 1985;121(2):172-173.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Allergic contact dermatitis from the use of skin care products and cosmetics containing chloracetamide has been reported in several countries in Europe.¹ Apparently, no such cases have occurred in the United States. The US distributor of this preservative states that chloracetamide is not presently registered or sold for use in cosmetics in the United States, although it is sold as an industrial biocidal preservative. Thus, it is logical to expect that chloracetamide contact allergy will not occur from cosmetic products in the United States. However, we recently encountered a case of contact allergy to chloracetamide due to purchase of an imported topical spray astringent formulated in France. We therefore wish to alert dermatologists to exposure to chloracetamide in imported cosmetics formulated abroad that may contain this potent sensitizer.

Report of a Case.—

A 40-year-old woman had a six-month history of a recurrent pruritic facial dermatitis that . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?